Oncolytics Biotech Market Cap

Oncolytics Biotech has a market cap or net worth of $105.41 million as of December 12, 2025. Its market cap has increased by 46.21% in one year.

Market Cap

105.41M

Enterprise Value

97.15M

1-Year Change

46.21%

Ranking

#4176

Market Cap Chart

Since September 30, 2002, Oncolytics Biotech's market cap has increased from $30.90M to $105.41M, an increase of 241.15%. That is a compound annual growth rate of 5.43%.

Market Cap History

Date	Market Cap	% Change
Dec 11, 2025	103.40M	46.88%
Dec 31, 2024	70.40M	-25.27%
Dec 29, 2023	94.20M	-0.95%
Dec 30, 2022	95.10M	24.48%
Dec 31, 2021	76.40M	-24.21%
Dec 31, 2020	100.80M	-15.44%
Dec 31, 2019	119.20M	341.48%
Dec 31, 2018	27.00M	-60.93%
Dec 29, 2017	69.10M	178.63%
Dec 30, 2016	24.80M	-1.59%
Dec 31, 2015	25.20M	-43.88%
Dec 31, 2014	44.90M	-62.24%
Dec 31, 2013	118.90M	-57.43%
Dec 31, 2012	279.30M	5.40%
Dec 30, 2011	265.00M	-35.74%
Dec 31, 2010	412.40M	260.49%
Dec 31, 2009	114.40M	129.72%
Dec 31, 2008	49.80M	-20.70%
Dec 31, 2007	62.80M	-17.04%
Dec 29, 2006	75.70M	-49.09%
Dec 30, 2005	148.70M	19.06%
Dec 31, 2004	124.90M	47.81%
Dec 31, 2003	84.50M	194.43%
Dec 31, 2002	28.70M	-7.12%
Sep 30, 2002	30.90M	-

View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	903.66B
Johnson & Johnson	506.41B
AbbVie	395.60B
UnitedHealth Group	305.01B
AstraZeneca	282.91B
Novartis AG	256.01B
Merck & Co.	245.75B
Novo Nordisk	223.42B

Market Cap Rankings